SEC industry · SIC 2836
The SEC classifies these issuers under “Biological Products, (No Diagnostic Substances)” (SIC 2836). A shared code is a starting point for finding comparable businesses. Product mix, geography and customers can still differ substantially. Read the company descriptions before treating the group as direct competitors.
This group has 2 disclosed fiscal year-end dates. Align the reporting periods before comparing annual results. The calendar below shows each company’s year end separately from its filing date.
SEC data snapshot: . The linked reports are the annual filings stored in that snapshot; newer filings may exist. This is a coverage directory, not a complete industry census or a ranking of investments. Multiple share classes of one issuer count as one company.
Amgen is one of the largest biotechnology companies, with therapies spanning cardiovascular disease, oncology, and inflammation. It is also advancing candidates in the fast-growing obesity-treatment market.
Bio-Techne makes reagents, proteins, and instruments used in biological research and diagnostics.
Biogen develops treatments for neurological diseases such as multiple sclerosis and Alzheimer's.
Gilead is a biopharmaceutical company with leadership in HIV and viral-disease treatments. It has expanded into oncology through acquisitions and its cell-therapy platform.
Moderna develops messenger-RNA vaccines and therapeutics, including its COVID-19 vaccine.
Compare Amgen Inc. and Biogen Inc.: business context, fiscal calendars and official filings.
Compare Amgen Inc. and Gilead Sciences, Inc.: business context, fiscal calendars and official filings.
Compare Amgen Inc. and Moderna, Inc.: business context, fiscal calendars and official filings.
Compare Amgen Inc. and Bio-Techne Corporation: business context, fiscal calendars and official filings.
Compare Biogen Inc. and Gilead Sciences, Inc.: business context, fiscal calendars and official filings.
Compare Biogen Inc. and Moderna, Inc.: business context, fiscal calendars and official filings.
Industry codes and annual filing references come from the SEC submissions snapshot linked to each issuer in our company catalog. Only groups with at least three distinct issuers, business descriptions and annual filing links are included.
SEC Standard Industrial Classification code list explains the classification system. Read our research methodology or browse all industry directories.
This page is company context and filings. Members get one sourced monthly call, a weekly evidence check, and the breakpoint written in advance. $15/month or $150/year.
$15/mo or $150/yr · cancel future renewals anytime · sources included